Wall Street had a slew of upgrades and downgrades from analysts. Here are some of the major calls for the week: J.P. Morgan ...

PTC Therapeutics faces pivotal FDA decisions for approvals that could potentially transform their long-term revenues. Click ...

From innovation in manufacturing to more-flexible regulation and better communication with payers, much needs to happen to ...

Vinay Prasad, head of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA), ...

Niemann-Pick Disease Type C (NPC) is a rare genetic disorder caused by mutations in the NPC1 or NPC2 genes, leading to harmful lipid accumulation in organs like the liver and brain. Symptoms, often ...

The abrupt exit of the former CBER director raises questions about the FDA’s leadership. For now, newly appointed CDER head ...

President Trump announced a trade deal with South Korea on Wednesday, putting 15 percent tariffs on South Korean goods, much ...

For some clients, the safer, the better as far as investing goes. And for others, future uncertainty is a concern they want to tackle head-on, while protecting what they’ve already earned.

US stock futures rise before Fed as Wall Street holds its breath for a pivotal decision on interest rates and key earnings reports from tech giants like Microsoft and Meta. Markets are slightly up on ...